Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS and Opioids: The Role for Non-Drug Reimbursements

This article was originally published in RPM Report

Executive Summary

The Centers for Medicare and Medicaid Services proposed Part D rules to give plans some responsibility for monitoring opioid abuse. But providers at a Senate Finance Hearing think CMS reimbursements beyond drugs can have a role in screening abuse – and in treating pain to begin with.

You may also be interested in...

The Pharmacy Police? House Hearing Pushes CMS To Do More To Limit Opioid Abuse In Part D

The 21st Century Cures legislation provides CMS with new authority to limit Part D beneficiary access to pharmacies and providers when there is concern about misuse or abuse of prescriptions. Now legislators want CMS to do even more.

Part D Program Integrity: What CMS Won’t Do

The HHS Inspector General says CMS is doing a lot to prevent waste, fraud and abuse in Part D. But the IG report also identifies some tools CMS isn’t using – and says it doesn’t want.

Improving Drug Safety – Without FDA: HHS Adverse Event Report Focuses On Other Agencies

HHS is declaring a priority of reducing the burden of adverse events associated with three large classes of drugs: opioids, antidiabetics, and anticoagulants. And, at least in its draft action plan, FDA is not the central actor.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts